Laboratories, Inc. Recalls Atenolol Tablets and Robot Ready Cards
August 4, 1999
Rockford, IL (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that UDL Laboratories, Inc. is recalling Atenolol
Tablets and Robot Ready Cards (Aminocaproic Acid) because of content uniformity failure.
Atenolol Tablets, USP, 25 mg, in unit dose packages
of 100 (10 strips/10 tablets) and Robot Ready Cards (25 cards of 1 tablet), Rx oral
beta-selective beta-adrenergic receptor blocking used in the management of hypertension
and angina pectoris. NDC #51079-759-20 and NDC #517079-759-19.
Lot Numbers: 9B254, 9A124, 8M577, 8P694.
Lederle Pharmaceutical, Division of American Cyanamid,Pearl River, New York.
UDL Laboratories, Inc., Rockford, Illinois, by letter dated June 25, 1999.
Firm-initiated recall ongoing.
27,394 unit cartons of 100 tablets and 1,582 unit cartons of 25 tablets were
distributed; firm estimated that 20 percent of the products remained on market at time of